Try Alerts Free   |   Login
Health Care › Pharmaceutical Preparations

Abbott Laboratories (ABT) Financials and Smart Investor 13F Alerts

See how revenue, income, cash flow, and balance sheet financials have changed over 45 quarters since 2010. Compare with ABT stock chart to see long term trends.

ABT stock compared to

ABT Income Statement

Revenue, Net:10456000000
Revenue Per Share:5.88
Cost of Goods & Services Sold:4401000000
Selling, General & Admin Expense:2783000000
Research & Development Expense:654000000
Total Operating Expenses:8347000000
Operating Income:2109000000
Income Taxes:250000000
Net Income:1793000000
Earnings Per Share, Basic:1
Shares Outstanding, Basic Avg:1776842000

ABT Cash Flow

Operating Activities Net Income:
Change in Accounts Receiveable:-165000000
Net Cash from Operations:2637000000
Repurchases/Buybacks Common Stock:275000000
Cash Dividends Paid:800000000
Net Cash from Financing Activities:-967000000
Property, Plant & Equipment Purchases:397000000
Net Cash from Investing Activities:-422000000
Net Change in Cash & Equivalents:1216000000

ABT Balance Sheet

Cash and Cash Equivalents:8054000000
Short-Term Investments:318000000
Accounts Receivable, Net:6096000000
Inventories:5387000000
Total Current Assets:21817000000
Property, Plant & Equipment, Net:8832000000
Total Assets:72785000000
Current Portion of Long-Term Debt:756000000
Total Short-Term Liabilities:12462000000
Long Term Debt, Non-Current Portion:17489000000

Major Holders (from 13F filings)

Investment Type
Change
Value (x$1000)
increase or decrease
Vanguard Group Inc
148,155,501 sh
-1,883,336 sh
-1%
$16,123,764
$2,405,714
Blackrock Inc.
135,019,032 sh
273,599 sh
0%
$14,694,122
$2,374,346
Wellington Management Group Llp
35,005,383 sh
-921,527 sh
-3%
$3,809,636
$524,838
Northern Trust Corp
27,028,098 sh
-6,414 sh
0%
$2,941,468
$469,702
Bank Of America Corp /De/
26,317,545 sh
26,105,445 sh
12308%
$2,864,139
$2,844,747
Morgan Stanley
25,371,069 sh
568,480 sh
2%
$2,761,133
$493,432
FMR LLC
15,081,213 sh
1,816,377 sh
14%
$1,641,289
$428,485
Ameriprise Financial Inc
13,371,780 sh
1,672,578 sh
14%
$1,456,575
$387,034
Legal & General Group Plc
11,365,348 sh
135,441 sh
1%
$1,236,889
$210,280
Charles Schwab Investment Management Inc
10,981,111 sh
-414,585 sh
-4%
$1,195,075
$153,165
UBS Asset Management Americas Inc
8,507,561 sh
121,985 sh
1%
$925,877,856
$159,184,644
Royal Bank Of Canada
7,787,614 sh
620,612 sh
9%
$847,527
$192,250
Goldman Sachs Group Inc
6,651,562 sh
6,495,662 sh
4167%
$723,890
$709,636
Primecap Management Co/Ca/
6,559,512 sh
-115,270 sh
-2%
$713,872
$103,597
Invesco Ltd.
5,679,235 sh
5,674,635 sh
123362%
$618,073
$617,654
Fayez Sarofim & Co
4,491,437 sh
144,195 sh
3%
$488,803
$91,334
American Century Companies Inc
4,330,579 sh
-262,159 sh
-6%
$471,297
$51,383
Price T Rowe Associates Inc /Md/
4,074,605 sh
-914,357 sh
-18%
$443,439
-$12,702
Prudential Financial Inc
3,777,495 sh
309,541 sh
9%
$411,104
$94,030
California State Teachers Retirement System
3,282,249 sh
-5,079 sh
0%
$357,207
$56,647

Data imported from Abbott Laboratories SEC filings. Check original filings before making any investment decision.